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Abstract
Barrier epithelia that are persistently exposed to microbes have evolved potent immune tools to eliminate such pathogens.
If mechanisms that control Drosophila systemic responses are well-characterized, the epithelial immune responses remain
poorly understood. Here, we performed a genetic dissection of the cascades activated during the immune response of the
Drosophila airway epithelium i.e. trachea. We present evidence that bacteria induced-antimicrobial peptide (AMP)
production in the trachea is controlled by two signalling cascades. AMP gene transcription is activated by the inducible IMD
pathway that acts non-cell autonomously in trachea. This IMD-dependent AMP activation is antagonized by a constitutively
active signalling module involving the receptor Toll-8/Tollo, the ligand Spa ¨tzle2/DNT1 and Ect-4, the Drosophila ortholog of
the human Sterile alpha and HEAT/ARMadillo motif (SARM). Our data show that, in addition to Toll-1 whose function is
essential during the systemic immune response, Drosophila relies on another Toll family member to control the immune
response in the respiratory epithelium.
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Introduction
Although the innate immune system is a primitive host defense
mechanism, it involves a sophisticated repertoire of humoral and
cellular responses both acting systemically and locally [1]. In
recent years, the Drosophila model organism has proven to be an
invaluable system in dissecting in great details the genetics and
cellular mechanisms regulating the innate immunity [2–3]. One
fundamental mechanism common to humans and Drosophila
immunity involves signaling by receptors of the Toll family. Upon
microbial infection, human TLRs activate the synthesis of
cytokines and other regulatory molecules that stimulate the
adaptive immune system [4]. In Drosophila, Toll signalling leads
to the activation of the systemic immune response, which is
characterized by the synthesis of AMPs by the fat body cells [5].
Upon secretion into the circulating blood, these AMPs provide
systemic protection against fungi and bacteria. In the mammalian
innate immune response, bacteria are directly sensed by TLRs [6].
In contrast, these microorganisms are detected in Drosophila by
another class of proteins, the Peptidoglycan Recognition Proteins
(PGRPs), also present in the human proteome [7–9]. Recognition
of Lys-type peptidoglycan (PGN) (mainly found in Gram-positive
bacteria cell wall) by the circulating PGRP-SA protein triggers a
protease cascade involving successively Mod-Sp, Grass, and the
Spa ¨tzle-Processing-Enzyme (SPE) [8,10–11]. Upon activation,
SPE becomes competent to transform the zymogen pro-Spa ¨tzle
into an active ligand for the Toll receptor, inducing its
dimerization and intracellular signalling [12]. Production of AMPs
after infection by Gram-negative bacteria, is however largely
independent of the Toll pathway but rather relies on another NF-
kB signalling cascade named IMD [13]. Sensing of Gram-negative
bacteria upstream of the IMD pathway takes place at the plasma
membrane, through PGN recognition by the transmembrane
PGRP-LC receptor. Binding of DAP-type PGN (present in Gram-
negative bacterial cell wall) to PGRP-LC induces its dimerization,
which, in turn, triggers IMD-dependent intracellular events
enabling the nuclear translocation of the NF-kB transcription
factor Relish [14–17].
Although penetration of infectious microbes into the body
cavity, and consequently, activation of a systemic immune
response, is a rare event, interactions between microbes and
epithelia take place constantly throughout the life of all metazoan.
This implies that these barrier epithelia must be armed with
efficient systems for microbial detection and elimination. Howev-
er, these epithelia that act as interfaces with the external
environment, share some characteristics that could be seen as
detrimental for the needs of an effective immune system. Indeed,
they usually have large surface areas and consist of thin structural
layers, thus representing ideal entry points for pathogens. In this
respect, the airway epithelium is unique among all epithelia, since
it has a very delicate structure and is constantly exposed to a
plethora of airborne pathogens. This could explain the occurrence
of a great variety of inflammatory lung diseases, including asthma,
chronic obstructive pulmonary disease or cystic fibrosis [18–19].
Elucidation of the primary steps that lead to chronic inflammation
of the mammalian lung is obstructed by the complexity of
inflammatory responses in this organ. Animals with a much
simpler organization, such as the fruit fly, might help us clarify the
basic architecture of this epithelial immune response, thereby
helping to unravel the mechanisms that lead to chronic
inflammation of the airways. Although of much simpler organi-
PLoS Pathogens | www.plospathogens.org 1 October 2011 | Volume 7 | Issue 10 | e1002319zation, the fly’s airway system shows striking similarities with the
mammalian lung regarding both its architecture and its physiology
[20–25].
In this report, we present a detailed description of the
mechanisms that regulate AMP production in the Drosophila
respiratory epithelium. We show that, in contrast to systemic fat
body immune response, the IMD pathway can be activated non-
cell autonomously in the tracheal network. We present evidence
that IMD pathway activation is tightly regulated in the cells of the
respiratory epithelium. We demonstrate that the molecular
mechanisms underlying IMD down-regulation following infection,
are different from those previously reported in the gut and in the
fat body, and rely on a dialog between two antagonist pathways.
The production of AMPs in the trachea is positively regulated by
the IMD pathway, which is counterbalanced by a negative
regulation from a signalling cassette, whose upstream receptor is a
member of the Toll family, Toll-8/Tollo. Our data suggest that
the Spz2/DNT1 cytokine is a putative Tollo ligand in this process,
and that Ect4, the Drosophila ortholog of the human Toll/
Interleukin-1 Receptor (TIR) domain-containing protein SARM
mediates Tollo signalling during tracheal immune response.
Results
AMP activation followed a stereotypical pattern in the
Drosophila tracheal network
The tracheal system is a relatively simple model system that has
provided an important insight into the biology of branching
morphology [22]. It is a tubular structure covered by a lumenal
cuticular lining that forms a physical barrier against dehydration
and invading microorganisms [20]. This network consists of a
monolayer epithelium made up of two dorsal trunks (DT)
connected to several visceral branches (VB) bringing oxygen to
internal tissues. Upon infection by the entomopathogenic
bacterium Erwinia carotovora carotovora (Ecc), these epithelial cells
produce a cocktail of AMPs including Drosomycin, Drosocin and
Attacin [26–27]. In order to perform a detailed spatiotemporal
analysis of this epithelial response, we used a Drosomycin-GFP
reporter transgene (Drs-GFP) and monitored the response of this
tissue after infection. When reared on conventional medium, a few
larvae showed sporadic tracheal Drs-GFP expression mainly in VB,
and rarely in the posterior part of the DT, namely the posterior
spiracles (PS) (Figure 1A and 1B). This basal Drs-GFP tracheal
expression was qualitatively and quantitatively similar in larvae
reared conventionally or under axenic conditions (data not shown).
Upon infection with Ecc, Drs-GFP activation followed a somewhat
stereotypical pattern. Responding larvae were categorized into
three classes according to their Drs-GFP expression pattern
(Figure 1A and 1C), namely, larvae expressing GFP in PS and
in posterior VB only (class I), in PS and all VB (class II) and in VB
and DT (class III). Kinetic experiments showed that GFP signal
was first detected in PS and then spread into VB (Figure 1A, C).
The reporter was only later activated in the DT and,
unexpectedly, first in the anterior half and then in the entire
trunk (Figure 1A). Although we appreciate that the expression
patterns of reporter transgenes can slightly deviate from those of
the actual AMP, the Drs-GFP expression patterns observed cannot
easily be attributed to a progressive diffusion of bacterial elicitors
(such as PGN) from the spiracles into the tracheal network, but
rather speak for more complicated mechanisms in tracheal AMP
activation.
IMD pathway activation is not strictly cell autonomous in
the trachea
Next, we compared the mode of activation of AMP following
forced immune pathway activation in the trachea and in another
immune tissue, the fat body. Although activation of Drosomycin
transcription is mainly controlled by the Toll pathway in the fat
body (but can be activated by ectopic IMD pathway triggering, see
later), it is strictly IMD-dependent in the trachea [5,26,28].
Indeed, over-activation of the IMD (UAS-PGRP-LCa, UAS-IMD),
but not of the Toll pathway (UAS-spz act, Tl
3), is sufficient to
induce tracheal expression of Drs-GFP in non-infected larvae
(Figure S1A and S1B). Concomitantly, loss-of-function mutations
in IMD pathway components (Relish, PGRP-LC, IMD) prevent
Drs-GFP tracheal activation in infected larvae, whereas Toll
signalling mutants such as spz or Dif do show a wild-type tracheal
response upon infection. To analyze whether all tracheal cells were
competent to trigger AMP production upon IMD pathway
activation, we induced UAS-IMD expressing clones in tracheal
cells, using fat body clones as controls. Overexpression of IMD led
to a strictly cell-autonomous and fully penetrant activation of both
Drs-GFP and Dipt-Cherry in the fat body (Figure 2B and 2C). In the
trachea, although most IMD-expressing cells showed Drs-GFP
expression, a fraction did not (Figure 2A). In addition, Drs-GFP
activation was not always associated with the expression of the
UAS-IMD transgene (Figure 2A), suggesting that IMD pathway
activation in trachea is not strictly cell autonomous. These results
were confirmed by using a UAS-PGRP-LCa transgene that
activated Drs-GFP both autonomously and non-autonomously in
trachea cells (Figure 2E) but strictly cell-autonomously in the fat
body (Figure 2F). We next addressed whether PGRP-LC function
was required cell-autonomously for IMD pathway activation in the
trachea upon infection. Analysis of MARCM loss-of-function
clones for PGRP-LC indicates that tracheal cells mutant for
PGRP-LC were totally impaired in their ability to trigger Drs-GFP
expression, following Ecc infection (Figure 2D and H). These
results indicate that, although PGRP-LC is essential in tracheal
cells for IMD pathway triggering, IMD pathway activation in one
tracheal cell can spread to neighboring cells. This contrasts with
the strictly cell-autonomous IMD-dependent immune response
observed in fat body cells.
Tollo is expressed apically in the Drosophila trachea cells
In order to get a further insight into the mechanisms that
control AMP induction in trachea, we looked for putative immune
Author Summary
Invertebrates solely rely on innate immune responses for
defense against microbial infections. Taking advantage of
its powerful genetics, the fly Drosophila melanogaster has
been extensively used as a model system to dissect the
molecular mechanisms that control innate immunity. This
work led to the discovery of the essential role of the Toll-1
receptor in triggering the systemic immune response in
flies, and paved the way for the discovery of the function
of members of the Toll-like receptor (TLR) family in
mammalian immunity. Whereas all TLRs are implicated in
the mammalian immune response, Toll-1 was, so far, the
only Drosophila Toll family member to be involved in the
regulation of the immune response. In the present study,
we show that another Toll family member, Toll-8 (Tollo),
plays an important role in controlling the respiratory
epithelium immune response. Our data indicate that, by
antagonizing the IMD pathway, Tollo is preventing over-
activation of the antibacterial response in the airway
epithelium.
Tollo and Drosophila Airway Immune Response
PLoS Pathogens | www.plospathogens.org 2 October 2011 | Volume 7 | Issue 10 | e1002319genes expressed in this tissue. A recent report identified the
repertoire of all immune genes expressed in the trachea [29]. One
of the striking data of this study, [confirmed by FlyAtlas (http://
flyatlas.org/)] was that, in addition to Toll itself, two other Toll
family members, 18-Wheeler (Toll-2) and Tollo (Toll-8), are
strongly expressed in trachea. 18-wheeler being implicated in
developmental processes with indirect impacts the immune
response [30], we focused our study on the putative function of
the Tollo transmembrane protein in the tracheal immune
response. Using Lac-Z reporter lines (data not shown) and q-
Figure 1. Spatio-temporal expression of tracheal Drosomycin-GFP. (A) Dorsal view of Drs-GFP third instar larvae. In non-infected larvae,
sporadic GFP expression is visible in posterior spiracles (PS) and/or in visceral branches (VB). Upon Ecc infection, larvae display a highly reproducible
pattern of GFP expression, classified as follow: Class I, PS + posterior VB only; Class II, PS + all VB; Class III, VB + dorsal trunk (DT), with Drs-GFP first in
the anterior half (limit marked by arrows) and only later, in the entire trunk. FB: fat body. (B) Quantification of tracheal Drs-GFP-positive larvae and
distribution of classes upon Ecc infection. Each histogram corresponds to the mean value of 5 experiments. A total number of 100 larvae were
counted for each experiment. Statistics apply for the ‘‘no signal’’ and the class III categories only. Values indicated by identical symbols (* or **) are
not significantly different (P.0.05) from one another. All other differences are statistically significant (P,0.05). (C) Quantification of tracheal Drs-GFP-
positive larvae at 4h, 8h, 12h and 24h post-infection by Ecc. Each histogram corresponds to the mean value of 3 experiments. A total number of 90
larvae were counted for each experiment.
doi:10.1371/journal.ppat.1002319.g001
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enriched in the tracheal epithelium, and expressed at lower levels
in other tissues. To investigate the subcellular localization of the
Tollo protein, we genetically associated a UAS-Tollo::Myc construct
with the trachea-specific Breathless-Gal4 driver (Btl-Gal4). Anti-Myc
antibody staining suggested that Tollo was localized apically at the
cell membrane facing the airway lumen (Figure 3B). Double
staining experiments showed that Tollo::Myc partially co-localized
with the apical marker Cadherin::GFP, but was mutually exclu-
sive with Viking::GFP, a basal membrane-associated protein
(Figure 3B). These results indicate that Tollo is a protein enriched
in the tracheal epithelium with an apical subcellular localization.
AMPs are specifically over-produced in infected Tollo
mutant trachea
The rather restricted expression pattern of Tollo mRNA in the
trachea and the apical subcellular distribution of Tollo protein
prompted us to investigate its putative function in the immune
response. For that purpose, we used two previously characterized
hypomorphic alleles (Tollo
145 and Tollo
R5A) together with a
complete loss-of-function allele (Tollo
C5) that we generated by P-
element mediated homologous recombination [31–32] (Figure
S2A). All Tollo mutants were viable with no obvious developmental
defects and gave rise to phenotypically normal pharate adults
indicating that Tollo has no essential role in Drosophila develop-
ment. We tested the ability of these Tollo mutant larvae to mount
an immune response. In the absence of infection, approximately
5% of wild-type larvae showed Drs-GFP expression in VB and/or
PS (Figure S3). Similar Figures were obtained with Tollo mutants
suggesting that Tollo is not required to set up the basal level of
AMP production in the absence of infection (Figure S3). After
bacterial infection, however, the immune response was much
stronger in Tollo mutants than in wild-type sibling larvae (Figure 4A
and 4B and Figure S3). While we could identify the three
previously described classes of Drs-GFP positive larvae in both
control and Tollo mutants, the relative proportion of these was
significantly different between genotypes (Figure S3). The
percentage of larvae showing no GFP expression was reduced to
5–10% in Tollo mutant (compared to 40% in controls), whereas
Class III larvae, which represented 15% of controls, reached up to
50% in the Tollo mutant larvae (Figure S3). Similar results were
obtained with three independent Tollo alleles and in trans-
heterozygous allelic combination demonstrating that this pheno-
type was, indeed, due to Tollo inactivation and not to other
mutations on the chromosome (data not shown). The effects were
not only qualitative but also quantitative. In most infected Tollo
Figure 2. IMD pathway activation is not strictly cell-autonomous in trachea. IMD overexpressing clones in trachea (A) and fat body (B, C)
cells are marked by RFP (A, B) or GFP (C) expression. (A) IMD overexpression activates Drs-GFP cell-autonomously (66%, n=68) (arrow) and non-
autonomously (12%, n=68) (dashed arrow) in the trachea. Note that 34% (n=68) of IMD-expressing cells are unable to activate Drs-GFP (arrow head).
On the contrary, 98% (n=38, for Drs-GFP) and 97% (n=57, for Dpt-Cherry) of IMD-expressing cells activate Drs-GFP (B) Dpt-Cherry (C) in a strictly cell-
autonomous fashion in the fat body. Clones overexpressing PGRP-LCa in trachea (E) and fat body (F, G) are marked by RFP (E, F) or GFP (G) expression.
Tracheal cells expressing PGRP-LCa activate Drs-GFP autonomously (74%, n=46) (arrow) and non-autonomously (39%, n=46) (arrow head) (E). Fat
body cells expressing PGRP-LCa (99%, n=48 for Drs-GFP) and (98%, n=63 for Dpt-Cherry) activate Drs-GFP (F) and Dpt-Cherry (G) autonomously. RFP
expressing clones never activates Drs-GFP cell-autonomoulsy (0%, n=52) nor cell non-autonomously (0%, n=52) in the trachea. (D, H) Visceral
branches of Ecc-infected larvae containing PGRP-LC mutant clones, marked by RFP expression (MARCM see Methods). Cells lacking PGRP-LC (red) are
unable to activate Drs-GFP expression, while surrounding cells do (green). Nuclei are stained with Dapi (blue). Scale bar is 100 mm.
doi:10.1371/journal.ppat.1002319.g002
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rarely the case in controls (Figure 4A). q-RT-PCR experiments
indicate that Drosomycin, Drosocin and Attacin mRNA levels were
respectively increased by 6, 7 and 2.6 fold after infection in Tollo
mutants compared to wild-type trachea (Figure 4B). To ensure
that this effect was indeed a consequence of Tollo inactivation in
the tracheal network itself, we combined the Btl-Gal4 driver with a
UAS-Tollo
IR RNA interference construct. As shown in Figure 4A
and Figure S3, larvae, in which Tollo was eliminated specifically in
trachea, also showed increased Drs-GFP expression in this tissue
after infection.
In addition to regulating Drosomycin expression in the trachea,
the IMD pathway also controls Diptericin transcription locally in
the gut and systemically in the fat body [13,26]. To test whether
Figure 3. Apical localization of Tollo protein in tracheal cells. (A) Tollo mRNA levels detected by q-RT-QPCR in third instar larval tissues.
Histograms correspond to the mean +/- SD of 3 experiments. Tollo expression in total larva extract was set at 1. (B) Larval trachea expressing a
Tollo::Myc fusion detected with an anti-Myc antibody (red) and expressing the basal membrane fusion protein Viking::GFP (green, left panels) or the
apical marker Cadherin::GFP fusion (green, right panels). Z sectioning shown in smaller panels indicate that Tollo::Myc co-localizes with the
Cadherin::GFP fusion and is excluded from the basement membrane. Both confocal stacks (large panels) and Z sectioning (small panel) are shown.
Nuclei are stained with Dapi (blue). Scale bar is 50 mm.
doi:10.1371/journal.ppat.1002319.g003
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mechanisms in other immune tissues, we analyzed the effects of
inactivating Tollo on IMD pathway activation in the gut and the
fat body. Using the Dipt-Cherry reporter construct for the larval
stage (Figure 4D) and q-RT-PCR for both larval and adult stages
(Figure 4E and 4F), we showed that Tollo was not implicated in
IMD negative regulation in either tissue. This was the case for
both immune responses induced by septic injury or by oral
ingestion. In addition, we showed that Tollo mutants were
unaffected in their ability to activate the Toll pathway during a
Gram-positive bacteria-mediated systemic immune response
(Figure 4F). Altogether these results demonstrate that the Tollo
receptor is specifically required to dampen IMD pathway-
dependent responses in the tracheal network after infection.
AMP over-production in Tollo mutants is not secondary
to trachea defects
Since AMPs are induced upon cellular stress, we tested whether
Drosomycin expression in Tollo mutants was a secondary conse-
quence of a possible implication of Tollo in tracheal formation. The
following reasons led us to believe that it was not the case. 1) Tollo
mutant embryos gave rise to viable adults, suggesting that Tollo
mutant trachea are fully functional in larvae and adults. 2)
Tracheal cell morphology of Tollo and control larvae appeared
similar when observed under transmission electron microscopy
(Figure 5A). 3) No constitutive AMP transcription was detected in
non-infected Tollo mutant larvae (Figure 4B and Figure S3). We
then wondered whether Drosomycin over-activation could be linked
to the presence of higher levels of potential immune elicitors in
Tollo mutant and RNAi trachea. This could be due to the presence
of higher bacterial load in the trachea. However, as shown in
Figure 5B and Figure S4B, the number of Ecc-GFP in Tollo mutant
trachea was identical in Tollo mutants and in controls. Alterna-
tively, Tollo mutant trachea could be more permeable to
contaminated external fluid. To test this hypothesis, wild type
and Tollo mutant larvae were incubated in the presence of a
fluorescent dye, bromophenol blue. External fluid penetration
inside the trachea lumen was not different in wild-type and Tollo
mutant larvae (Figure 5C and 5D). This indicates that over-
activation of Drosomycin in both Tollo mutant and RNAi trachea
cannot be attributed to an increase in fluid penetration, and
therefore putative immune elicitor load within the tracheal lumen.
Altogether, these results demonstrate that the infection-dependent
Drosomycin over-activation observed in Tollo mutant, is not
secondary to defective trachea but rather suggests a direct
implication of the Tollo protein in the regulation of IMD-
dependent Drosomycin expression.
Ect4/SARM and DNT1/Spa ¨tzle 2 loss-of-function mutants
phenocopy Tollo mutants
We then tried to identify the intra- and extra-cellular
components that may mediate Tollo signalling in trachea. The
Drosophila Toll-1 receptor and vertebrate TLR functions have all
been shown to be mediated by TIR domain-containing proteins,
respectively, the Drosophila dMyd88 and the mammalian Myd88,
TRIF, SARM, TRAM and MAL [33–35]. However, the
Drosophila proteome contains two TIR domain proteins, Ect4/
SARM the Drosophila ortholog of vertebrate SARM and dMyd88,
the latter mediating the Toll signalling during dorso-ventral axis
specification and immune response [36–38]. In order to test
whether Tollo acts through a TIR domain-containing protein, we
analyzed the tracheal immune response of dMyd88 and Ect4/
SARM mutants. We showed that larvae carrying Ect4/SARM
mutations (Figure S2B) display a strong over-activation of
Drosomycin expression (visualized with the Drs-GFP reporter
transgene and quantified by q-RT-PCR) upon infection, pheno-
type that was not observed in dMyd88 mutant larvae (Figure 6A
and 6B and Figure S5A). This suggests that Ect4/SARM is the
bone fide TIR domain adaptor transducing Tollo signalling in the
tracheal immune response. Whereas TLRs function as Pattern
Recognition Receptors by directly binding to microbial motifs,
previous work has shown than the Drosophila Toll-1 receptor is
activated during both embryonic dorso-ventral axis specification
and immune response by its ligand Spa ¨tzle [39–40]. Since spz
mutant larvae did not present higher activation of Drs-GFP in the
respiratory tract after infection, we believe that Spz is not a
functional ligand for Tollo (Figure 6C). Since Spz-like genes are
present in the fly genome, we screened them for a Tollo-like
phenotype. We observed that removing Spz2 (known as DNT1)
function in trachea phenocopies Tollo mutant as far as Drosomycin
over-activation is concerned (Figure 6C and 6D and Figure S5B).
This suggests that DNT1 could be the, or one of the ligand(s),
responsible for Tollo activity in the tracheal immune response.
Similarly to Tollo, q-RT-PCR data indicate that Ect4 and DNT1
are specifically acting in the tracheal epithelium and do not
contribute to IMD pathway regulation in the gut and in the fat
body (Figure 6B and 6D).
Tollo is hypostatic to IMD in the trachea
Taking into account the above results, it appears that the
function of Tollo is specifically to down-regulate the IMD pathway
in the tracheal cells following infection. In order to genetically
place Tollo with respect to known IMD pathway components, we
performed epistatic experiments. We showed that the Tollo mutant




















R5A). The enhanced Drs-GFP expression observed in Tollo mutants is abolished when
in conjunction with PGRP-LC or imd mutations. Images were taken 24h after Ecc infection. VB: visceral branch, DT: dorsal trunk, FB: fat body. (B)
Infection-triggered AMP expression is enhanced in Tollo mutant trachea derived from third instar larvae (L3). The mRNA level post-infection in control
flies (Tollo
C5/+) was set to 100, and values obtained with other genotypes were expressed as a percentage of this value. Each histogram corresponds
to the mean value +/2 SD of 3 experiments. Values indicated by identical symbols (* or **) are not significantly different (P.0.05) from one another.
All other differences are statistically significant (P,0.05). (C) The enhanced Drosomycin mRNA induction in Tollo single mutants is lost when in
conjunction with PGRP-LC or imd mutations. mRNA levels post-infection in control flies (OregonR) was set to 100, and values obtained with other
genotypes were expressed as a percentage of this value. Each histogram corresponds to the mean value +/2 SD of 3 experiments. Values indicated
by identical symbols (*, ** or ***) are not significantly different (P.0.05) from one another. All other differences are statistically significant (P,0.05).
(D) Dorsal view and confocal pictures of Ecc-infected larvae of the following genotypes: Control (Tollo




R5A, Dpt-Cherry). Pv: pro-ventriculus, Vtr: posterior end of ventriculus, Post CC: posterior to copper cells, Post mg: posterior
midgut. Scale bar for confocal pictures is 100 mm. (E, F) Systemic AMP expression after infection in larvae (E) or in adults (F). The mRNA level post-
infection in control flies (Tollo
C5/+) was set to 100, and values obtained with other genotypes were expressed as a percentage of this value. Each
histogram corresponds to the mean value +/2 SD of 3 experiments. Values indicated by identical symbols (* or **) are not significantly different
(P.0.05) from one another. All other differences are statistically significant (P,0.05).
doi:10.1371/journal.ppat.1002319.g004
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PLoS Pathogens | www.plospathogens.org 7 October 2011 | Volume 7 | Issue 10 | e1002319Figure 5. Tracheal morphology, putative immune elicitors and fluid penetration in trachea are not affected by Tollo mutations. (A)
Electron microscopic pictures of tracheal transversal sections of control (Oregon R), Tollo mutant (Tollo
C5/Tollo
R5A), Ect4 mutant (Ect4
EY04273/
Df(3L)ED4408)o rDNT1 mutant (DNT1
41/DNT1
41) third instar larvae. No obvious morphological differences could be observed between control and
mutant trachea. (e) epicuticle, (t) taenidium, (p) procuticle and (bm) basement membrane. Scale bar is 2 mm. (B) Midgut and tracheal load of Ecc-GFP
in control (Tollo
C5/+) and Tollo mutant (Tollo
C5/Tollo
R5A) third instar larvae, 4h and 24 h post-infection. Note that bacterial load for Ecc-GFP is much
Tollo and Drosophila Airway Immune Response
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- trachea did not show any signs of Drs-GFP activation
after infection (Figure 4A). This epistatic relationship was
confirmed by q-RT-PCR on Drosomycin mRNA (Figure 4C). In
genetic terms, Tollo is hypostatic, or acts in parallel to PGRP-LC
and imd. Consistently, Relish nuclear translocation monitored with
an anti-Relish antibody was higher in Tollo RNAi-infected tracheal
cells than in controls (Figure S6). These results suggest that Tollo is
not directly involved in IMD pathway activation per se but that, in
its absence, IMD pathway activation is more efficient upon
infection.
Discussion
Epithelial responses are first and foremost local responses to
prevent the epithelium from unnecessary immune reactions. Since
the recognition steps in Drosophila respiratory epithelia involve the
transmembrane receptor PGRP-LC and occur within the
extracellular space, it is expected that molecular mechanisms
must be at work to prevent constitutive or excessive immune
response in this tissue, particularly essential for animal growth and
viability. In this report, we present data demonstrating that the
transmembrane receptor Tollo is part of a signalling network,
whose function is to specifically down-regulate AMP production in
the trachea. We show that Tollo antagonizes IMD pathway
activation in the respiratory epithelium, and that DNT1/Spz2 and
Ect4/SARM are putative Tollo ligand and transducer, respec-
tively, in this process. Our data demonstrate that, in addition to
the family founder Toll-1, another member of the Leucine-Rich-
Repeats family of Toll proteins, is regulating the Drosophila innate
immune response. Although it has been abundantly documented
that every single mammalian TLR has an immune function [4],
the putative implication of Toll family members, other than Toll-1
itself, in the Drosophila immune response has been a subject of
controversy [41]. Data showing that Drosophila Toll-9 over-
expression was sufficient to induce AMPs expression in vivo has
prompted the idea that Toll-9 could maintain significant levels of
anti-microbial molecules, thus providing basal protection against
microbes [42]. However, our recent analysis of a complete Toll-9
loss-of-function allele has shown that this receptor is neither
implicated in basal anti-microbial response nor required to mount
an immune response to bacterial infection [43]. The present data
are also fully consistent with a recent report showing that Toll-6,
Toll-7 and Toll-8 are not implicated in systemic AMP production
in flies [44], and demonstrate that a Toll family member, Tollo, is
a negative regulator of local airway epithelial immune response
upon bacterial infection. In contrast to Toll-1, whose activation is
inducible in the fat body, Tollo pathway activation seems to be
constitutive in the trachea. Despite these differences, both
receptors use a member of the Spz family as ligand. Interestingly,
sequence similarities, intron’s size and conservation of key
structural residues, indicate that Spz2/DNT1 is phylogenetically
the closest family member to the Toll ligand Spz [45].
Furthermore, both Spz and Spz2/DNT1 have been shown to
have neurotrophic functions in flies [46]. It would be of great
interest to test whether Tollo also mediates Spz2 function in the
nervous system.
Both during embryonic development and immune response,
Spz is activated by proteolytic cleavage [10,47-48]. This step
depends upon the Easter protease that is implicated in D/V axis
specification and on SPE for Toll pathway activation by microbes.
Since Spz orthologs are also produced as longer precursors, they
are likely to be activated by proteolysis. The fact that Tollo and
Spz2 loss-of-function phenotypes correspond to excessive AMP
production, suggests that in wild-type conditions, the Tollo
pathway is constitutively activated by an active form of the Spz2
ligand. This situation is reminiscent to that observed in the
embryonic ventral follicle cells, in which a Pipe-mediated signal
induces a constitutive activation of the Easter cascade leading to
Spz cleavage, Toll activation and, in turn, ventral fate acquisition
[49]. It should be noted that Easter and one Pipe isoform are very
strongly expressed in the trachea cells (Flyatlas), and are candidate
proteins in mediating Tollo activity in the respiratory epithelia.
The fact that Ect4, but not dMyd88 mutant, loss-of-function
mutant phenocopies Tollo mutant suggest that Ect4 could be the
TIR domain adaptor transducing Tollo signal in the tracheal cells.
Alternatively, Ect4/SARM could mediate Tollo function by
interfering with IMD pathway signalling. In mammals, SARM is
under the transcriptional control of TLR and negatively regulates
TLR3 signalling by directly interfering with the association
between the RHIM domain-containing proteins TRIF and RIP
[50]. Since PGRP-LC contains a RHIM domain as TRIF, and
IMD is the Drosophila counterpart of RIP, one can envisage that
Drosophila SARM could act by interfering with the PGRP-LC/
IMD association required for IMD pathway signalling. Similarly
to its function as a negative regulator in fly immunity, SARM is
the only TIR domain-containing adaptor that acts as a suppressor
of TLR signalling [36,50].
One obvious question relates to the mode of action of Tollo on
IMD pathway downregulation. Two mechanisms have been
recently described that result in the down-regulation of the IMD
pathway. The first one regulates PGRP-LC membrane localiza-
tion, and is dependent on the PIRK protein [51–53]. Upon
infection, the intracellular PIRK protein is up-regulated and, in
turn, represses PGRP-LC plasma membrane localization leading
to the shutdown of the IMD signalling [53]. In infected pirk
mutants, IMD-dependent AMPs are overproduced in both the gut
and the fat body. In our conditions, however, inactivation of PIRK
specifically in the trachea did not influence Drosomycin activation in
trachea (Figure S7A). To verify whether Tollo is acting via a
mechanism similar to PIRK, we looked at PGRP-LC membrane
localization using a UAS-PGRP-LC::GFP construct. PGRP-LC
membrane localization was identical in wild-type and Tollo mutant
tracheal cells (Figure S7B). The second mechanism that modulates
IMD activation, acts directly on the promoters of IMD target
genes. Ha et al. (2005) have shown that the Caudal transcription
factor sits on some of the IMD target promoters preventing their
activation by Relish [54]. We thus tested the putative implication
of Caudal in Tollo signalling by using Drs-GFP reporter transgenes
containing either wild-type Caudal Responsive Elements (CDREs)
or mutated versions unresponsive to Caudal activity [55]. Upon
weaker in trachea when compare to midgut. Colony forming units (CFUs) per tissue are shown for each condition. n=6 in triplicates. (C) Example of
control larvae (Btl-Gal4) without (top panels) or with (bottom panels) red fluorescent BPB in trachea (arrow). Dorsal views of third instar larvae are
shown. Pictures were taken 24 h after Bromophenol Blue (BPB) incubation. (D) Quantification of (BPB) entry in trachea of non-infected larvae. BPB
entry is rare (around 5%) and not affected by Tollo mutations (Tollo
C5/Tollo
R5A), Tollo RNAi (Btl-Gal4;UAS-Tollo
IR) or infection (data not shown). Each
histogram corresponds to the mean value +/2 SD of 3 experiments. A total number of 90 larvae were counted for each experiment. Values indicated
by identical symbols (*) are not significantly different (P.0.05) from one another.
doi:10.1371/journal.ppat.1002319.g005
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but not in gut or trachea (Figure S7C). In conclusion, Caudal acts
as a transcriptional activator, rather than a repressor, for the Drs-
GFP reporter in trachea. These results indicate that Tollo does not
regulate the IMD pathway via PGRP-LC membrane localization
or through promoter targeting of Caudal. One challenging task for
the future will be to identify the mechanism used by Tollo to
counter-balance tracheal PGRP-LC activation. It has been
reported that the loss of Tollo function in ectodermal cells during
embryogenesis alters glycosylation in nearby differentiating
neurons [31,56–57]. Since the pattern of oligosaccharides
expressed in a cell can influence its interactions with others and
with pathogens, Tollo could function by modifying glycosylation
pattern in response to microbes. It could be envisaged that Tollo
mediates PGRP-LC glycosylation, and thereby reduces its ability
to respond to bacterial elicitors. Further work will be required to
address the above hypothesis, whereby Tollo activity and
glycosylation modification could be linked in order to regulate
the IMD pathway activation in trachea.
Material and Methods
Bacterial strains
The following microorganisms were used: Erwinia carotovora
carotovora 15 2141 (Ecc), Erwinia carotovora carotovora 15 pOM1-GFP
spectinomycin
R (Ecc-GFP), Escherichia coli 1106 (E.coli) and Micrococcus
luteus CIPA270 (M. luteus).
Bacterial load analysis
Bacterial load of surface sterilized individuals was quantified by
plating appropriate serial dilutions of lysates obtained from 6
dissected guts or trachea (from larvae) on nutrient agar plates
(Luria Bertani + spectinomycin 100 mg/ml). Biological triplicates
were collected for each experimental condition at 4h and 24h after
Ecc-GFP infection. Homogenization of tissues was performed using
the Precellys 24 tissue homogenizer (Bertin technologies, France)
and 0,75-1mm glass beads in 500 mLo fL B+ spectinomycin.
Drosophila melanogaster strains and maintenance
PGRP-LC
DE12 is a complete deletion of the PGRP-LC locus [16].
Flies carrying this mutation are unable to activate the IMD pathway.
spz
rm7 is a null allele which prevents Toll pathway activation [5]. yw,
Drs-GFP [27], Dpt-Cherry [58], Tollo




IR (VDRC #9431), UAS-Tollo::Myc [31],
DNT1
41 [46], UAS-spz2
IR (VDRC #26115), Ect4
EY04273 BL#15733,
Df(3L)ED4408 BL#8065, Tl
3 BL#3238 (a dominant gain-of-
function allele of Tl, Btl-Gal4 BL#8807, UAS-myrRFP BL#7118,
act.CD2.Gal4 BL#4780, cad-EGFP BL#30875, Vkg-GFP (a gift
from Michel Se ´me ´riva), hs-Gal4 BL#2077, Relish
E20 [60], imd
1 [5],
UAS-spz act [30], dMyd88
c03881 [34], UAS-PGRP-LC::GFP (a gift from
Franc ¸ois Leulier) and Dif
1 [61]. Generation of the Tollo
C5 allele was
performed as described in [62] using the two following inserted
elements: d01565 and PBacf05248 [63]. Complete deletion of the
Tollo gene was confirmed by sequencing genomic DNA extracted
fromTollo
C5mutants (molecular details upon request). Fly stocks were
raised on standard cornmeal-agar medium at 25uC.
Natural infection of larvae and adults
Cells from overnight bacterial cultures were recovered by
centrifugation at 4,000 g for 10 min at 4uC. The supernatant was
discarded and the pellet was resuspended in fresh LB media. Cell
suspensions were serially diluted in PBS, and the concentration of
cells was determined by optical-density (OD) measurement. 200 ml
of an overnight bacterial culture of Ecc (OD=200) were directly
added on top of feeding third instar larvae into a standard
cornmeal-agar medium at 25uC. A similar volume of LB broth was
used in control experiments. Larvae were monitored for Drosomycin
and Diptericin transcription by fluorescence analysis using Drs-GFP
and Dpt-cherry reporters respectively, and by qRT-PCR, 24h after
infection. Septic injuries were performed by pricking adult males
with a thin needle contaminated with M. luteus or E. coli. 200 mlo f
Bromophenol Blue (SIGMA # B8026) at 10 g/l were directly
added on top of feeding third instar larvae.
Flip-out clones and MARCM
For Drs-GFP study, Drs-GFP;UAS-myrRFP;act.CD2.Gal4 fe-
males were crossed to either ywhsflp;;UAS-IMD or to ywhsflp;; UAS-
PGRP-LCa males. For Dpt-Cherry study, ywhsflp; UAS-GFP;
act.CD2.Gal4 females were crossed to Dpt-Cherry; UAS-IMD or
to Dpt-Cherry, UAS-PGRP-LCa males. In both cases, larvae of the
progeny were heat shocked at early-mid L3 stage (72h-96h after
egg deposition, AED) and observed 24 h later. Generation of
MARCM clones in trachea was performed by crossing MARCM
virgin females of genotype ywhsflp;; Tub-Gal80 FRT2A en masse to
the Drs-GFP; Blt-Gal4, UAS-myrRFP; PGRP-LCD
E12 FRT2A line.
Resulting embryos were submitted to a heat shock 4–6 hr AED for
1h ra t3 8 uC in a circulating water bath, and kept at 25uC until
larvae reached early-mid third instar (72h-96h AED), when they
were infected by Ecc and observed 24 h later.
Immunostaining on larvae
Larval tissue were dissected in PBS and fixed for 20 min in 4%
paraformaldehyde on ice. After several rinses in PBT (PBS + 0.1%
Triton X-100), they were blocked for 1 hr in PBT-3% BSA at 4uC
and then incubated with antibody at the appropriate dilution in
PBT-BSA 3% overnight at 4uC. Primary antibodies were: rabbit
Anti-Relish (1:500) or Mouse Anti-Myc (9E10 Santa Cruz at 1:
500). Several washes in PBT were followed by a 2 hr incubation
with secondary antibody at RT (Alexa Fluor 546 goat anti-rabbit
IgG and Alexa Fluor 555 goat anti-mouse IgG diluted 1:500,
Molecular Probes), then 5 washes in PBT. The tissues were finally
mounted in Vectashield (Vector Laboratories) fluorescent mount-
Figure 6. The TIR domain-containing protein Ect4/SARM and the cytokine DNT1/Spz2 negatively regulate tracheal immune








c03881) and Dif- (Drs-GFP;Dif
1/Dif
1). (B) Infection-triggered AMPs expression is enhanced in Ect4 mutant trachea,
but not in gut or fat body. mRNA levels post-infection in control flies (Ect4
EY04273/+) was set to 100, and values obtained with other genotypes were
expressed as a percentage of this value. Each histogram corresponds to the mean value +/2 SD of 3 experiments. Values indicated by identical










rm7). VB: visceral branch, DT:
dorsal trunk, FB: fat body. Pictures were taken 24h after infection. (D) Infection-triggered AMPs expression is enhanced in DNT1 mutant trachea, but
not in gut or fat body. The mRNA level post-infection in control flies (DNT1
41/+) was set to 100, and values obtained with other genotypes were
expressed as a percentage of this value. Each histogram corresponds to the mean value +/2 SD of 3 experiments. Values indicated by identical
symbols (* or **) are not significantly different (P.0.05) from one another. All other differences are statistically significant (P,0.05).
doi:10.1371/journal.ppat.1002319.g006
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Zeiss confocal microscope.
Quantitative real-time PCR
Quantitative real-time PCR and SYBR Green analysis were
performed as previously described [58]. Primer information can be
obtained upon request. The amount of mRNA detected was
normalized to control rp49 mRNA values. Normalized data was
used to quantify the relative levels of a given mRNA according to
cycling threshold analysis (DCt).
Electronic microscopy
For electron microscopic sections, third instar larvae trachea
were dissected and fixed at RT in 4% PFA and 2% glutaraldehyde
in 0.12 M sodium cacodylate buffer at pH 7.4 for 1 h. The
trachea were then washed 3610 min in 0.12 M sodium cacodylate
buffer, post-fixed in 2% OsO4 in 0.12 M sodium cacodylate buffer
for 1 h and washed again 3610 min. Samples were subsequently
dehydrated through series of ethanol gradients and infiltrated with
propylene oxide, embedded in epoxy resin (Fluka, Sigma) and
polymerized at 80uC. Ultrathin (80 nm) plastic sections were cut
using a Leica UltraCut microtome with a diamond Diatome knife
and post-stained with 2% uranyl acetate, followed by treatment
with Reynolds’lead citrate, and stabilized for transmission EM by
carbon coating. Examination was performed with a Zeiss Leo 912
microscope at 100 kV. Images were captured using a Gatan 792
Bioscan camera using Digital Micrograph software.
Supporting Information
Figure S1 Ecc-mediated Drs-GFP activation in the
trachea is IMD-dependent and Toll-independent. (A)
Dorsal views of Drs-GFP larvae of the following genotypes: UAS-
IMD (Drs-GFP;hs-Gal4/+;UAS-imd/+), UAS-PGRP-LCa (Drs-GFP;hs-














E20). In non-infected larvae, gain-of-function muta-
tions of IMD pathway components, but not of Toll pathway
components, aresufficientto promote intenseexpression of Drs-GFP
in trachea. Upon Ecc infection, Drs-GFP expression is lost in PGRP-
LC, imd orRelishmutants.Imagesweretaken 24hafterheat-shock or
Ecc infection. PS: posterior spiracles, VB: visceral branch, DT:
dorsal trunk, FB: fat body. (B) Quantification of Drs-GFP expressing
larvae is displayed as histograms. Statistics apply for the ‘‘no signal’’
and the Class III categories only.Each histogramcorresponds to the
mean value of 5 experiments. A total number of 80 larvae were
counted for each experiment. Values indicated by identical symbols
(*, ** or ***) are not significantly different (P.0.05) from one
another. All other differences are statistically significant (P,0.05).
(TIF)
Figure S2 Down regulation of Tollo mRNA in Tollo
mutants and Tollo RNAi larvae and down regulation of
Ect4 mRNA in Ect4 mutant. (A) Tollo mRNA detection by q-
RT-PCR is shown for total third instar larvae or dissected trachea.
Tollo mRNA measured in wild-type (OregonR) larval tissue was set
to 100, and values obtained with other tissues were expressed as a
percentage of this value. Histograms correspond to the mean +/-
SD of 3 experiments. Values indicated by identical symbols (* or
**) are not significantly different (P.0.05) from one another. All
other differences are statistically significant (P,0.05). (B) Ect4
mRNA detection by q-RT-PCR is shown for dissected trachea.
Ect4 mRNA measured in wild-type (OregonR) larval tissue was set to
100, and values obtained with other tissues were expressed as a
percentage of this value. Histograms correspond to the mean +/-
SD of 3 experiments. Values indicated by different symbols (* and
**) are significantly different from one another (P,0.05).
(EPS)
Figure S3 Negative regulation of tracheal immune
response by Tollo. Quantification of Drs-GFP expressing larvae
in various genotypes. Tracheal expression of Drs-GFP in Ecc-
infected larvae is enhanced by either Tollo mutations or Tollo
RNAi-mediated inactivation. Statistics apply for the ‘‘no signal’’
and the class III categories only. Each histogram corresponds to
the mean value of 8 experiments. A total number of 120 larvae
were counted for each experiment. Values indicated by identical
symbols (*, ** or ***) are not significantly different (P.0.05) from
one another. All other differences are statistically significant
(P,0.05).
(EPS)
Figure S4 Bacterial penetration into larval trachea
upon Ecc infection. (A) Ecc-GFP localization in trachea of
wild-type larvae. Ecc-GFP can be found either in posterior spiracle
(PS), visceral branches (VB) or dorsal trunk (DT). Pictures were
taken 24h after infection. (B) Histograms show quantification of
larvae with Ecc-GFP positive trachea in control (Tollo
C5/+ and Btl-
Gal4)o rTollo mutants (Tollo
C5/Tollo
R5A) and Tollo RNAi (Btl-Gal4;
UAS-Tollo
IR) third instar larvae. Each histogram corresponds to the
mean value of 5 experiments. A total number of 100 larvae were
counted for each experiment. Values indicated by identical
symbols (*) are not significantly different (P.0.05) from one
another.
(EPS)
Figure S5 The TIR domain-containing protein Ect4
(SARM) and the cytokine Spz2 (DNT1) negatively
regulate tracheal immune response. (A, B) Quantification
of Drs-GFP expressing larvae in various genotypes. Statistics apply
for the ‘‘no signal’’ and the class III categories only. Each
histogram corresponds to the mean value of 3 experiments. A total
number of 80 larvae were counted for each experiment. Values
indicated by identical symbols (*, ** or ***) are not significantly
different (P.0.05) from one another. All other differences are
statistically significant (P,0.05).
(EPS)
Figure S6 Nuclear localization of Relish is increased in
Tollo RNAi trachea. Confocal images representative of control
or Tollo RNAi trachea from Ecc-infected larvae and stained with
anti-Relish antibody (Red). Nuclei are stained with Dapi (blue).
Scale bar is 50 mm.
(EPS)
Figure S7 Negative regulation by Tollo does not involve
PIRK,PGRP-LC membrane localization or Caudal Re-
sponsive Elements. (A) Quantification of Drs-GFP expressing
larvae in various genotypes. Tracheal expression of Drs-GFP in
Ecc-infected larvae is unaffected by pirk RNAi-mediated inactiva-
tion. Statistics apply for the ‘‘no signal’’ and the class III categories
only. Each histogram corresponds to the mean value of 8
experiments. A total number of 80 larvae were counted for each
experiment. Values indicated by identical symbols (* or **) are not
significantly different (P.0.05) from one another. All other
differences are statistically significant (P,0.05). (B) Tollo is not
affecting PGRP-LC::GFP membrane localization in trachea.
Confocal images representative of control or Tollo mutant trachea
expressing a PGRP-LC::GFP fusion protein, in third instar larvae.
The apical localization of PGRP-LC::GFP is un-affected by Tollo
mutations. The following genotypes are shown: Tub-Gal4, Tub-
Tollo and Drosophila Airway Immune Response
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R5A. A total number of 30 trachea were observed for
each genotype. Images were taken 24h after incubation at 29uC.
(C) Image representative of Ecc-infected Drs(CDREmut)-GFP larvae
is shown with no GFP signal visible in trachea (lower panel). The
CDREs of Drosomycin promoter are required for tracheal
expression upon Ecc infection. A total number of 50 larvae were
analyzed. Images were taken 24h after Ecc infection.
(EPS)
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